Overview

A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions

Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the rate and extent of absorption of Actavis Group hf, Iceland, finasteride and Merck & Co. Inc., U.S.A. (Proscar), finasteride, administered as a 1 x 5 mg tablet, under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Actavis Inc.
Treatments:
Finasteride